Introduction
g-Retroviral and lentiviral vectors are currently the most commonly used gene delivery vehicles due to their ability to permanently integrate a therapeutic transgene into a target cell chromosome. [1] [2] [3] [4] Lentiviral vectors have the unique feature of being able to transduce nondividing cells, making it particularly attractive for certain gene therapy applications. [5] [6] [7] Sometimes, to achieve a desirable therapeutic effect, the viral vectors must be capable of precisely delivering a gene of interest to specific cells without influencing non-target cells. [8] [9] [10] Many efforts have been made to develop such targeting viral vector systems mostly by altering the viral envelope glycoprotein. [11] [12] [13] [14] [15] [16] Although certain envelope glycoproteins are structurally plastic enough to allow insertion of a new molecular recognition unit (such as peptide, single chain antibody, growth factor and so on) for targeting, this manipulation can adversely affect the delicate coupling interactions of the binding and fusion domains of glycoproteins, resulting in enveloped vectors with decreased infectivity to the target cells. 8, 15, [17] [18] [19] We have previously developed an efficient method to target lentivirus-mediated gene transduction to a desired cell type. 10 Our engineering approach involved the incorporation of a targeting antibody and pH-dependent fusogenic protein as two distinct molecules on the lentiviral surface. Our hypothesis for targeted transduction was that antibody binding induces endocytosis, and then the virus is brought into an endosomal compartment where the low pH environment causes the fusogenic molecule to trigger membrane fusion and release the viral core into the cytosol. To understand the interactions between the engineered lentivirus and the targeted cells and the underlying mechanisms of viral transduction at a molecular level, we intended to develop assays to directly visualize the intracellular behavior of the virus in living cells.
Improved understanding of virus-host cell interactions can provide crucial insights for enhancing the efficacy of virus-mediated gene delivery as well as preventing virus-triggered diseases. Insight into the dynamics of the trafficking of viral particles in living cells is fundamental to understanding a variety of the viral infection mechanisms. Many enveloped viruses enter their host cells via receptor-mediated endocytosis. The endocytosed viruses are internalized through endocytic compartments, and the viruses fuse with the endosomal membrane to release viral genome into host cells. [20] [21] [22] [23] During these processes, viruses utilize microtubule networks for movement toward the perinuclear regions. 24, 25 Recent studies have shown that intracellular virus trafficking is critically involved in the endosomemediated sorting and transport of influenza virus, vesicular stomatitis virus (VSV) and Semliki Forest virus. [26] [27] [28] The endocytic pathways used by some viruses have been explored, but some specific features of the entry mechanisms of engineered recombinant lentiviruses remain largely unknown.
In this study, we analyzed the intracellular trafficking of the targeting lentiviral vectors by utilizing dynamic imaging of single viruses within target cells. We visualized the incorporated molecules on a single virion and the targeting of antibody-displaying virus to a CD20-expressing cell line. We also imaged viral fusion and detected the endosome-associated transport of the engineered lentivirus. Our results suggest that virusendosome fusion takes place at the early endosome stage, and that viral fusion is independent of microtubule-or actin-associated transport. We also observed the process of the dissociation of the viral core from the fused endosome. Our results shed some light on the infection model of the targeting lentiviral vector incorporated with two separated binding and fusion proteins on the surface.
Results
Coincorporation of antibody and fusogenic protein on the engineered virion We sought out imaging methods to characterize a previously engineered lentivirus reported to be able to selectively transduce human B cells via CD20 as the viral receptor. 10 Codisplay of an anti-CD20 antibody and a fusogenic protein on the same virion is thought to be essential for this engineered lentivirus to infect the target cell. To image the virus, we constructed lentiviral particles harboring green fluorescence protein (GFP) fused to the N-terminus of the HIV accessory protein viral protein R (designated GFP-Vpr; Figure 1a ). GFPVpr-labeled lentivirus enveloped with both anti-CD20 antibody and fusogenic protein, which were produced as described, 10 except with the use of lentiviral backbone plasmid FUW lacking the GFP transgene ( Figure 1a ) instead of FUGW and cotransfection of an additional plasmid that expresses GFP-Vpr. During virus synthesis, GFP-Vpr provided in trans can be incorporated into the virion via interaction between Vpr and the P6 region of the gag protein. 29 To determine whether aCD20 (anti-CD20 antibody) and SINmu (fusogenic protein) 10 were incorporated on the same virion, we indirectly immunofluorescent stained the GFP-Vpr-tagged virions by a triple labeling method ( Figure 1b) . As controls, we also included the staining of the GFP-Vpr-labeled lentiviral particles bearing various surface proteins (FUWGFPVpr/aCD20, FUW-GFPVpr/SINmu or FUWGFPVpr/VSVG); vesicular stomatitis viral glycoprotein (VSVG) is a widely used envelope glycoprotein with broad tropism. Confocal images of the individual FUWGFPVpr/aCD20+SINmu particles showed that B70% of the GFP-Vpr-labeled virions colocalized with both aCD20 and SINmu (Figure 1c ). This indicated that both the antibody and the fusogenic protein were indeed displayed on a single virus particle. The detection of a few GFP-negative and dye-positive spots for FUWGFPVpr/aCD20+SINmu suggested that some of the intact virions lacked the GFP-Vpr protein, which is consistent with the previous report by McDonald et al.
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; some spots that were positive for SINmu only could be virions that lacked the incorporation of the GFP-Vpr protein and aCD20. As expected, colocalizations of the GFP-labeled virions with only aCD20 (FUW-GFPVpr/ aCD20) or with only SINmu (FUW-GFPVpr/SINmu) were observed, whereas no colocalization of the GFPlabeled virions with either protein was detected for FUW-GFPVpr/VSVG.
To test whether the GFP-Vpr-labeling of lentiviruses could affect the viral infectivity, we made viruses bearing both aCD20 and SINmu (FUGW/aCD20+SINmu); FUGW is a lentiviral backbone that contains a human ubiquitin-C promoter driving the expression of a GFP transgene (Figure 1a) . 30 The target 293T/CD20 cells were exposed to FUGW/aCD20+SINmu with or without the incorporation of GFP-Vpr, and the percentage of GFPexpressing cells was measured by fluorescence-activated cell sorting (FACS) 3 days postinfection. As shown in Figure 1d , a similar transduction efficiency was obtained, indicating that the GFP-Vpr-labeling did not markedly affect viral infectivity.
Antibody directs lentivirus to target cells
To examine whether the engineered lentiviral particles could efficiently recognize the desired cell type, we analyzed the virus-cell binding complex using a confocal microscope. A 293T cell line stably expressing the CD20 protein (293T/CD20) was used as the target cell line, and its parental cell line 293T was used as a negative control (Supplementary Figure 1A) . Neither GFP nor the aCD20 signal was detected in the control 293T cells lacking CD20 expression (Supplementary Figure 1A, upper) . In contrast, significant GFP and aCD20 signals were detected on the surface of 293T/CD20 cells (Supplementary Figure 1A , lower). This result suggests that our engineered lentivirus can specifically bind to a CD20-expressing cell line.
To further confirm that the virus-cell binding was induced by the viral aCD20, the lentiviral particles bearing various surface proteins (FUW-GFPVpr/ aCD20+SINmu, FUW-GFPVpr/aCD20 or FUWGFPVpr/SINmu) were incubated with 293T/CD20 cells, followed by extensive washing. The imaging results showed that the lentiviral particles bearing the aCD20 antibody (FUW-GFPVpr/aCD20+SINmu and FUWGFPVpr/aCD20) were able to bind to the target cells, but no GFP signal was detected in the cells incubated with the viral particles bearing only the fusogenic protein SINmu (FUW-GFPVpr/SINmu; Supplementary Figure  1B ). These results demonstrate that the virus-cell binding is mediated by a specific interaction between the CD20 antigen on the cell surface and the aCD20 antibody on the viral surface. We quantified the number of viral particles bound to the target cells by examining more than 20 cells and counting the bound viruses. The result showed that FUW-GFPVpr/aCD20+SINmu (15.4 particles per cell) and FUW-GFPVpr/aCD20 (16.3 particles per cell) exhibited similar binding to 293T/CD20 cells, whereas FUW-GFPVpr/SINmu (0.1 particles per cell) was rarely detected on the cell surface.
Incorporated fusogenic protein triggers virus-endosome fusion
To visualize the actual fusion event of internalized viruses within the endosomes, we used lipophilic dye, 1,1 0 -dioctadecyl-3,3,3 0 ,3 0 -tetramethylindodicarbocyanine (DiD) that can be spontaneously incorporated into viral membrane for a double labeling of GFP-Vpr-tagged lentiviruses. The incorporation of DiD dye at a high concentration on the viral membrane can result in selfIntracellular trafficking of the engineered lentivirus K-I Joo and P Wang Intracellular trafficking of the engineered lentivirus K-I Joo and P Wang quenching of DiD fluorescence. 31, 32 Viral fusion with the endosome membrane can then cause a dequenching that is due to the dispersion of DiD and can be seen by the increase of fluorescence (Figure 2a) . We labeled GFP-Vprtagged lentiviruses (FUW-GFPVpr/aCD20+SINmu) with DiD and incubated them with 293T/CD20 cells at 37 1C Figure  2c (upper), and the boxed regions are enlarged and represented as panels below. At 0 min, the GFP-Vprlabeled viral particles were detected on the cell surface. After 10 min of incubation, viral particles appeared to be internalized inside the cell but remained detectable solely by the green signal, suggesting that although viruses were endocytosed, fusion had not occurred. The image after 30 min of incubation showed that many particles were fused with the endosomes, as indicated by the appearance of the red signal. After 60 min, more endosome-fused viral particles and brighter fusion signals were observed. These imaging results suggest that the majority of viral fusion occurs between 30-60 min after incubation. In addition, viral fusion was observed in the peripheral region at earlier time points (Figure 2c , upper, 30 min), but the fusion signals at later time points were mostly distributed around the perinuclear region of the cell (Figure 2c , upper, 60 min).
We compared the kinetics of viral fusion of our engineered lentivirus with that of conventional VSVGpseudotyped lentivirus. It is known that VSV is endocytosed to early endosomes, where low pH triggers endosomal fusion. 33 Using the same fluorescence dequenching assay, we observed the viral fusion of FUWGFPVpr/VSVG. The acquired images showed that virus-endosome fusion could be detected at 10 min after incubation (Figure 2c , lower), indicating that viral fusion of VSVG-pseudotyped lentivirus occurs faster than that of the engineered targeting lentivirus.
To compare the timing of acidic pH-activated and fusion-involved penetration of the engineered and VSVG-pseudotyped lentiviruses, we used bafilomycin A1, the specific inhibitor of vacuolar proton ATPases, to block low pH endosomal fusion. 34 Viruses were prebound to 293T/CD20 cells at 4 1C for 1 h, and entry was initiated by shifting cells to 37 1C. At different time points thereafter, bafilomycin A1 (25 nM) was added to block further viral fusion. The percentage of viral entry was normalized based on the signal at 4.5 h, when no further effect of bafilomycin A1 was observed and fusion was therefore considered to be unrestricted by the treatment. These results suggest that acid-induced penetration of VSVG-pseudotyped lentivirus occurred B5 min after warming, and a half-maximal penetration (50%) was reached by B40 min, whereas the penetration of engineered lentivirus (FUGW/aCD20+SINmu) took place B25 min after warming and reached a half maximal level by B120 min (Figure 2b) . Consistent with the viral fusion kinetics determined by the dequenching assay (Figure 2c ), we found that the engineered lentivirus has slower kinetics of viral penetration than that of VSVG-pseudotyped lentivirus.
To further characterize viral fusion, we performed real-time imaging of GFP-Vpr/DiD-labeled lentiviruses in 293T/CD20 cells. We first incubated the doubly labeled viruses with 293T/CD20 cells at 37 1C for 30 min to allow the internalization of viral particles, and then began imaging. Confocal time-lapse images were collected cautiously to make sure that the same viral particle was tracked at B15-s intervals over a period of 10 min and selected images are shown in Figure 2d (see also Supplementary Movie 1). The first image (at 334.7 s) showed that before endosomal fusion, the viral particle was identified only by green color. At 418.8 s, viral fusion with the endosome was visualized by the dramatic increase of fluorescence signal as the result of DiD dequenching (Figures 2d and e) . Approximately 80% of the viral particles we observed (n ¼ 34) showed this pattern of dequenching. Interestingly, the virusendosome fusion signal was initially detected around the peripheral region (418.8 s) and then migrated toward the nucleus over B3 min (Figure 2d) . We observed the movement of fusion signals toward nucleus in 60% of the videos recorded (n ¼ 14), whereas in the other 40% of cases, it appeared that the fusion signals were either stationary or bidirectional. As shown in Figure 2e , the quantification of fluorescence intensity of the GFP and the DiD signals showed that although some fluctuations of the GFP signal were detected during the imaging, only the DiD signal increased dramatically at certain moments of the recording, supporting our assumption that the observed fluorescence change is an indication of viral fusion.
Tracking of viral transport through endosomes
To visualize the distribution of endosomal compartments, we used antibodies against early endosome antigen 1 (EEA1) [26] [27] [28] and cation-independent mannose-6-phosphate receptor (CI-MPR) 26, 35 as the early and late endosomal markers, respectively. As shown in Figure 3a , the early and the late endosomal markers were largely separated. The early endosomal markers were distributed in the peripheral region, whereas the late endosomal markers were primarily found in the perinuclear region of cells. However, a close examination of the images identified several endosomes that were both EEA1-and CI-MPR-positive (Figure 3a, arrow) , which have been interpreted as maturing intermediates toward the late endosomes. 36, 37 These intermediate endosomes containing both markers were mostly observed in the perinuclear region of the cells.
We conducted a colocalization experiment to examine the endosomal transport of the engineered lentivirus and to analyze the virus-fused endosomes. As shown in Figure 3b , at 0 min, the viral particles did not colocalize with either of the endosomal markers. After 30 min of incubation, particles were colocalized with EEA1 in the early endosomes, and after 60 min, many viral particles were observed in endosomes positive for both EEA1 and CI-MPR. At 120 min, most of the viral particles did not colocalize with either marker, and a small fraction was seen in the late endosomes that stained positive only for CI-MPR. We quantified this colocalization by viewing more than 20 cells (B100 viruses) for each time point (Figure 3c ) and the results were consistent with the observation seen in Figure 3b . Coupled with the previous evidence that virus-endosome fusion signals were detected between 30 and 60 min after incubation ( Figure  2c ), this study suggests that the virus-endosome fusion started before the late endosome stage.
To confirm the trafficking of the viral particles through various endosomes, we further examined the colocalization of engineered viral particles with red fluorescent protein-tagged Rab protein, DsRed-Rab5 and DsRedRab7, as the early and late endosomal markers, respectively. 36, 38, 39 The time-course images showed that the majority of viral particles were first located in organelles that were positive for DsRed-Rab5 (Supplementary Intracellular trafficking of the engineered lentivirus K-I Joo and P Wang Next, we compared the trafficking of our engineered lentivirus with transferrin, which is known to be trafficked from early to recycling endosomes. 26 At 60 min, most of the viral particles were colocalized with both EEA1 and transferrin, and a small fraction (9%) of the viruses were observed in transferrin-positive only organelles, which could be considered as recycling endosomes (Supplementary Figure 2B, 60 min) . However, at 120 min, 30% of the viruses were colocalized with transferrin-positive, EEA1-negative organelles, indicating that some fractions of viruses were trafficked to recycling endosomes (Supplementary Figure 2B, 120 min) .
Microtubule-mediated virus transport
We further characterized the endosomal compartment where the viral fusion occurs by disrupting the microtubules. It has been reported that the microtubule network can facilitate the migration of viruses to the nucleus and promote the transport of endosomes in cells. 24, 25, 29 Our colocalization study using the tubulinspecific antibody suggested that the engineered lentiviruses travel along microtubule networks (Figure 4a ). To examine whether virus-endosome fusion occurs before or after microtubule-dependent transport, microtubules were damaged by the drug nocodazole. The reduced tubulin staining confirmed the disruption of microtubule networks (Figure 4b ). We next studied the effect of microtubule disruption on virus-endosome fusion and the confocal image showed that the viral fusion signals could be detected (Figure 4c) , and quantification indicated that the viral fusion is independent of microtubule assistance (Figure 5a) , suggesting that the viral fusion with endosomes occurs before microtubuleassociated movement. 
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To further investigate the effects of the microtubuledisrupting drug on the localization of virus in endosomal compartments, we pretreated cells with nocodazole for 30 min and quantified the viruses colocalizing with the different endosomal markers after 60 min of incubation. The results showed that the viral population in EEA1-and CI-MPR-double positive endosomes in nocodazoletreated cells was significantly lower than that of untreated cells, whereas the population positive only for EEA1 was higher in the treated cells (Figures 4d and  5c ). This indicated that viral particles were mostly located in the early endosomes devoid of CI-MPR upon nocodazole treatment and that the treatment restricted the further transport and maturation of early endosomes to EEA1-and CI-MPR-double positive endosomes. To investigate whether endosome maturation was relevant to productive infection of our engineered lentiviruses, nocodazole-pretreated cells were transduced by FUGW/ aCD20+SINmu. The FACS analysis showed that the transduction rate decreased by 31%, suggesting that productive infection was affected markedly by the nocodazole inhibition of the endosome maturation (Figure 5b ).
To confirm the role of microtubules in viral infection, we used small-interfering RNA (siRNA) to downregulate the expression of a-tubulin in cells. 293T/CD20 cells were transfected with a-tubulin-specific siRNA or control siRNA, and the knockdown of a-tubulin expression was validated by microtubule staining (Figure 4e) . The virus-endosome fusion experiment on the siRNA-treated cells showed that the downregulation of a-tubulin did not significantly affect the efficiency of viral fusion (Figures 4f and 5a) . Similar to the result of the nocodazole treatment, we also observed that the maturation of the lentivirus-containing endosomes was dependent on microtubule-associated transport, as most of these endosomes were retained at the early endosome stage after the siRNA-treatment (Figures 4g and 5c) . As compared to treatment of the control siRNA, lower transduction was obtained for 293T/CD20 cells transfected with a-tubulin-specific siRNA and exposed to FUGW/aCD20+SINmu (Figure 5d ).
Actin-mediated virus transport
We further investigated the role of actin cytoskeleton in trafficking the engineered viral particles. The colocaliza- Intracellular trafficking of the engineered lentivirus K-I Joo and P Wang tion study using rhodamine-conjugated phalloidin suggested that our engineered lentiviruses travel along actin-filaments (Supplementary Figure 3A) . To characterize actin-mediated virus trafficking, 293T/CD20 cells were pretreated with 20 mM of cytochalasin D (cyto-D) at 37 1C for 30 min to disrupt actin filaments, and then we examined the viral fusion and virus localization in endosomal compartments. We first confirmed the disruption of actin in cyto-D-treated cells by phalloidin labeling (Supplementary Figure 3B) . The viral fusion assay in the cyto-D-treated cells showed that the majority of viral particles (denoted by arrows) were fused with the endosomes (Figure 5a and Supplementary Figure  3C) . The viral population in endocytic markers showed that viral particles were mostly located in the early endosomes ( Figure 5c and Supplementary Figure 3D) . Compared to the results of microtubule disruption by either nocodozale or siRNA, actin disruption using cyto-D resulted in greater inhibition of the viral transduction ( Figure 5b ). This further confirmed that the inhibition of the maturation process of lentivirus-containing endosomes could affect productive infection.
Virus release from endosomes
It has been reported previously that Vpr remains largely associated with the preintegration complex after fusion, 29 thus, GFP-Vpr labeling can be used for visualizing the release of the viral core from fused endosomes. GFP-Vpr/DiD-labeled viruses (FUW-GFPVpr/aCD20+ SINmu) were incubated at 37 1C for 60 min to induce virus-endosome fusion; based on our study of fusion kinetics (Figure 2c) , most of the viruses should be retained in the endosomes at this stage. Confocal timelapse images were then acquired every B10 s over a time period of 20 min (Supplementary Movie 2) . At 0 s, the viral particle appeared to be yellow (a merged color of green and red), indicating that fusion had already taken place (Figure 6 ). At 461 s, the GFP-Vpr-labeled viral core (green) moved away from the DiD-labeled endosome (red), suggesting that the virus is being released into the cytosol. We recorded around 50 videos and 12 of them showed the similar process of virus release illustrated in Figure 6 . This seemingly low yield (24%) could be partially due to photo bleaching as a result of long-time exposure to the laser source during the recording. No virus release signal was detected for the control virus lacking SINmu (FUW-GFPVpr/aCD20; Supplementary Figure 4 ). This live cell imaging suggests that the completion of virus membrane fusion to release the viral core, which is required for the delivery of viral genome to the cell nucleus, is relatively long-term and possibly a sequential multistep process.
40,41
Figure 6 Time series images of the viral core release from an endosome starting 60 min after incubation. GFP-Vpr/DiD-labeled viruses (FUW-GFPVpr/aCD20+SINmu) were incubated with 293T/CD20 cells at 37 1C for 60 min to initiate virus fusion, and then time-series images were obtained at every B10 s over a time period of 20 min. Scale bar represents 2 mm.
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Discussion
In this study, we have visualized individual engineered lentiviruses and have analyzed the intracellular behavior of viruses in the target cells using single viral particle tracking via confocal microscope. GFP-Vpr labeling along with other immunostaining methods has allowed us to confirm the coincorporation of an antibody and fusogenic molecule on a single virion, separating the functions of binding and fusion, respectively. We have confirmed by the direct visualization of virus-host cell interactions that the antibody displayed on the virion surface targets a specific cell type and we have shown that viral particles were efficiently endocytosed upon antibody binding. Subsequently, the surface-displayed fusogenic molecule SINmu, 10 which is an engineered glycoprotein derived from the Sindbis virus that is binding deficient and fusion competent, mediated fusion in the acidic endosomal environment. By observing the trafficking of single lentivirus intracellularly, we have shed some light on the endocytic mechanisms of engineered lentivirus such as virus-endosome fusion and endosomal transport of viral particles in target cells.
By using a fluorescence dequenching assay, we have detected the actual fusion event of the GFP-Vpr/DiD double-labeled viral particle and monitored the dynamics of fusion in living cells. Colocalization studies using endocytic markers suggested that the endosomal fusion of the engineered lentivirus started at an early stage of the endocytic pathway. Inhibitory drug treatments showed that the transport and maturation steps of the virus-endosome complex from the early to the intermediate endosome require microtubule-or actinassisted transport. However, virus-endosome fusion was not restricted by the inhibition of microtubule-or actinassociated transport, suggesting that the majority of viral fusion begins at the early endosome level.
We also studied the fusion kinetics of the engineered lentivirus and compared it to VSVG-pseudotyped lentivirus, which is known to require low pH to mediate fusion. 42 It has been shown that the fusion of VSV occurs before the late endosome stage. 27 Our data suggest that it takes 70-80 min more for the engineered lentivirus to reach a half-maximum of fusion-involved penetration than it does for VSVG-pseudotyped virus. We suspect that one possible reason for this delay could be due to the separation of the functions of binding and fusion into two individual molecules on our targeting lentivirus system. The different requirements for fusion of different viruses could be another cause for the slower entry kinetics of the engineered lentivirus. For example, the Sindbis virus requires cholesterol for the endosomal fusion, whereas the fusion of VSV is independent of cholesterol. 43 We are conducting experiments to investigate the effects of such membrane components on the entry efficiency of the engineered lentivirus.
Using the real-time imaging of single viruses, we were able to observe the dynamics of virus-endosome fusion and transport. After the viral fusion signal was seen, we observed that many virus-containing endosomes (60%) moved toward the nucleus. As the lipophilic membrane dye is initially incorporated onto the outer membrane of the virus, the lipid mixing (that is, hemifusion) between the viral outer membrane and the endosomal inner membrane is initially visualized by the increase of DiDfluorescence. The fusion-pore formation and enlargement of the pore is believed to be required for the completion of the virus membrane fusion to release the viral core into the cytosol. 41, 44 Our live-cell imaging of viral release seems to support this hypothesis. From the experiments of the drug and siRNA treatments ( Figure  5a ), we have learned that the hemifusion (that is, lipid mixing) takes place before the late endosome stage. The reduced infectivity upon the drug and siRNA treatments (Figures 5b and d) indicates that the release of the viral core, which is a necessary step for a productive infection, is associated with the maturation process from the early to the intermediate endosomal compartments. This suggests that the virus is at least transported to the intermediate endosome to complete infection.
In summary, we demonstrated that the direct visualization of individual viruses can allow us to determine the endocytic pathway of the engineered lentivirus in living cells. The single-virus tracking techniques confirmed our hypothesis of the mechanism of targeted transduction for the engineered lentivirus. Our observations, based on the kinetics of entry of engineered lentivirus, indicate that the fusogen-mediated membrane fusion is a long process, which is markedly slower than that of VSVG-pseudotyped lentivirus, suggesting that this might be the rate-limiting step of virus transduction. Therefore, the development of fusogenic molecules, which induce more efficient and stable fusion could be a promising step in enhancing the lentivirus-mediated gene delivery efficacy.
Materials and methods

Cell lines and antibodies
The 293T/CD20 cell line was generated previously.
10
293T and 293T/CD20 cells were maintained in a 5% CO 2 environment in Dulbecco's modified Eagle's medium (Mediatech Inc., Manassas, VA, USA) with 10% fetal bovine serum (Sigma, St Louis, MO, USA) and 2 mM L-glutamine (Hyclone, Logan, UT, USA). Mouse monoclonal antibody specific to the human CD20 antigen were purchased from Caltag Laboratories (Carlsbad, CA, USA). Anti-HA-biotin to stain SINmu was obtained from Miltenyi Biotec Inc. (Auburn, CA, USA). Mouse monoclonal antibody against the EEA1, rabbit polyclonal antibody specific to CI-MPR and Cy5-conjugated goat anti-rabbit immunoglobulin G (IgG) antibody were purchased from Abcam (Cambridge, MA, USA). Cy5-conjugated streptavidin was purchased from Zymed Laboratories (South San Francisco, CA, USA). Texas redlabeled goat anti-mouse IgG and AlexaFluor 594-labeled goat anti-human IgG antibodies were obtained from Molecular Probes (Carlsbad, CA, USA). Taxol, nocodazole, cyto-D and bafilomycin A1 were purchased from Sigma.
Plasmids
Assembly PCR was employed to fuse the GFP to the N-terminus of Vpr. The PCR product was then inserted into pcDNA3 (Invitrogen, Carlsbad, CA, USA) to form pcDNA3-GFPVpr. The cDNAs for Rab5 and Rab7 were PCR-amplified and cloned into the pDsRed-monomer-C1 (Clontech, Mountain View, CA, USA) to form DsRedRab5 and DsRed-Rab7, respectively.
Intracellular trafficking of the engineered lentivirus K-I Joo and P Wang
Virus production GFP-Vpr-labeled lentiviruses were produced by transfecting 293T cells by a calcium phosphate precipitation method. 293T cells at 80% confluence in 6 cm culture dishes were transfected with 5 mg of the lentiviral plasmid FUW, together with 2.5 mg each of pcDNA3-GFPVpr, paCD20 (encodes a mouse/human chimeric anti-CD20 antibody), pIgab (encodes human Iga and Igb, two immunoglobulin associated proteins that are required for surface expression of antibodies), pSINmu and the packaging vector plasmids. 10 Cells were washed at 4 h posttransfection, and then medium was replaced. The viral supernatant was collected after 48 h posttransfection and filtered through a 0.45-mm pore size filter. For high-titer lentivectors, the viral supernatant was concentrated by ultracentrifugation (Optima L-90K ultracentrifuge, Beckman Coulter) for 90 min at 82 700 g and resuspended in an appropriate volume of Hank's balanced salt solution (Hyclone).
Viral transduction
For viral transduction, 293T/CD20 cells (0.2 Â 10 6 per well) were plated in a 24-well culture dish and spin infected with viral supernatants of FUGW/aCD20+SIN-mu (2 ml per well) at 2500 r.p.m. and 30 1C for 90 min by using a Sorval Legend centrifuge. Then, the medium was removed and replaced with fresh medium and cultured for 3 days further before FACS analysis of GFP + cells. For viral transduction with drug-or siRNA-treated cells, 293T/CD20 cells were preincubated with drugs (nocodazole (60 mM), cyto-D (20 mM) and bafilomycin A1 (25 nM)) or transfected with siRNAs, and then the cells (0.2 Â 10 6 per well) were spin-infected with 2 ml of viral supernatants in a 24-well culture dish.
Time-course study of fusion inhibition
293T/CD20 cells (0.4 Â 10 5 per well) were seeded in a 96-well culture dish overnight. Viruses were added to cells and incubated at 4 1C for 1 h and the resulting cells were washed with cold phosphate-buffered saline (PBS) to remove unbound viruses. The viral entry was initiated by shifting cells to 37 1C. At the indicated time points, D10 media containing 25 nM of bafilomycin A1 was added to inhibit the endosome acidification. The drug was removed 3 h later and replaced with fresh D10 media. Cells were further incubated for 72 h, and the percentage of GFP-positive cells was analyzed by FACS.
Fluorescent labeling
For the detection of individual viral particles, fresh viral supernatant was overlaid upon poly-lysine-coated no. 1 coverslips in a six-well culture dish and centrifuged at 3700 g and 4 1C for 2 h in a Sorval Legend RT centrifuge. The coverslips were rinsed with cold PBS twice, the adhered viruses were immunostained by Alexa 594 antihuman IgG and anti-HA-biotin antibodies, and they were then incubated with Cy5-streptavidin. The coverslips were mounted in Vectashield (Vector Laboratories, Burlingame, CA, USA), which is an antifade mounting medium. For imaging virus-cell binding, 5 Â 10 5 cells were seeded onto a 35 mm glass-bottom culture dish (MatTek Corporation, Ashland, MA, USA) and grown at 37 1C overnight. The seeded cells were rinsed with cold PBS twice and incubated with the concentrated viruses for 1 h at 4 1C to allow for binding. Cells were washed with cold PBS to remove unbound viruses and then fixed with 4% formaldehyde on ice for 10 min. To co-label the viral particles bound to the cell surfaces, Alexa594 antihuman IgG antibody was used to stain against the aCD20 heavy chain. Fluorescent images were taken by a Zeiss LSM 510 laser scanning confocal microscope equipped with filter sets for fluorescein, rhodamine or Texas red and Cy5. A plan-apochromat Â 63/1.4 oil immersion objective was used for imaging. Images were analyzed with the use of the Zeiss LSM 510 software version 3.2 SP2.
Imaging virus fusion and transport through endosomes
The concentrated viruses were incubated with 100 mM of DiD (Molecular Probes) for 1 h at room temperature. For imaging virus-endosome fusion, double-labeled viruses were incubated with 293T/CD20 cells at 37 1C for various time periods and then fixed with 4% formaldehyde. GFP-Vpr and DiD were excited simultaneously with a 488 nm Argon and a 633 nm HeNe laser, respectively, and the emitted light was separated through the corresponding emission filter sets. All samples were scanned under the same conditions for magnification, laser intensity, brightness, gain and pinhole size. For live cell imaging of virus fusion, 293T/ CD20 cells were preincubated on a glass bottom culture dish at 37 1C overnight. Viruses were incubated with the cells at 37 1C for 30 min to initiate virus internalization. Images were then collected using the confocal microscope. Fluorescence intensity vs time within the regions of interest around the virus particles were measured by using the Zeiss LSM 510 software package.
For observation of the colocalization of the virus with different endosomal markers, GFP-Vpr-labeled viruses were incubated with 293T/CD20 cells at 37 1C and fixed after different time periods. Cells were then permeabilized with 0.1% Triton X-100 and immunostained with EEA1 and CI-MPR for early endosome and late endosome markers, respectively. Texas red-conjugated antimouse IgG and Cy5-conjugated goat anti-rabbit IgG antibodies were used as the secondary antibodies. To remove viral aggregates, virus-containing media was filtered by a 0.45 mm pore size centrifuge tube filter (Costar, NY, USA) just before the experiments were conducted.
For the viral trafficking studies using Rab5 and Rab7 constructs, 293T/CD20 cells were transfected with DsRed-Rab5 or DsRed-Ran7 plasmid. At 48 h posttransfection, cells were seeded onto the glass-bottom culture dish and grown at 37 1C overnight. GFP-Vpr-labeled viruses at multiplicity of infection B30 were added and incubated at 37 1C for the different time points and then fixed.
For the colocalization study with transferrin, GFPVpr-labeled viruses and 2 mM of Alexa647-conjugated transferrin (Molecular Probes) were mixed and then incubated with 293T/CD20 cells at 37 1C for 60 or 120 min. Cells were fixed, permeabilized and immunostained with EEA1 to compare trafficking of the engineered lentivirus with transferring through early to recycling endosomes.
For the real-time observation of the release of the virus from the endosome, GFP/DiD-labeled viruses were incubated with cells at 37 1C for 1 h to induce virusIntracellular trafficking of the engineered lentivirus K-I Joo and P Wang endosome fusion, and confocal time-lapse images were then recorded.
Microtubule-mediated transport
To observe viruses on microtubule networks, the cells were incubated with GFP-Vpr-labeled viruses at 37 1C for 1 h, fixed and then permeabilized with 0.1% Triton X-100 containing 20 mM of taxol. Microtubules were then immunostained with anti-a-tubulin mAb (Sigma) and Texas red-conjugated anti-mouse secondary antibody. For the microtubule-disrupting assay, cells were preincubated with D10 media containing 60 mM of nocodazole at 37 1C for 30 min, and then viruses were added and incubated for further studies. For the inhibition assay using siRNA, we purchased atubulin siRNA and the negative control siRNA from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). The transfection of siRNA was performed as described by the manufacture's protocol. At 72 h posttransfection, equal numbers of a-tubulin siRNA and control siRNA treated 293T/CD20 cells were used for further studies.
Actin-mediated transport
To visualize viruses on actin filaments, the cells were incubated with GFP-Vpr-labeled viruses at 37 1C for 1 h, fixed and permeabilized. Actin filaments were labeled with rhodamine-conjugated phalloidin (Molecular Probes). For the actin-disrupting assay, cells were preincubated with D10 media containing 20 mM of cyto-D at 37 1C for 30 min, and then viruses were added and incubated for further studies.
